Candida auris, an evolving multidrug-resistant pathogenic yeast, is known for causing
severe invasive infections associated with high mortality rates in hospitalized individuals …

Human cathelicidin LL37 and its fragments LL13–37 and LL17–32 exhibited similar
potencies in inhibiting growth of the yeast Candida albicans. After treatment with 0.5 μM and …

Growth in biofilms as a fascinating and complex microbial lifestyle has become widely
accepted as one of the key features of pathogenic microbes, to successfully express their full …

Candida auris is a newly identified species causing invasive candidemia and candidiasis. It
has broad multidrug resistance (MDR) not observed for other pathogenic Candida species …

Candida auris is an emerging fungal pathogen of great concern among the scientific
community because it is causing an increasing number of hospital outbreaks of difficult …

Candida auris, a new multidrug-resistant Candida spp. which is associated with invasive
infection and high rates of mortality, has recently emerged. Here, we determined the …

Candida auris has been reported in the past few years as an invasive fungal pathogen of
high interest. Its recent emergence in healthcare-associated infections triggered the efforts of …

Candida auris has emerged as a serious threat of public health and caused global epidemic
due to multi-drug resistance, remarkable transmissibility and high mortality. To tackle the …

Candida auris is a multi-drug-resistant fungal pathogen that can survive outside the host and
can easily spread and colonize the healthcare environment, medical devices, and human …

Candida auris is an emerging, multi drug resistant fungal pathogen that has caused
infectious outbreaks in over 45 countries since its first isolation over a decade ago, leading …